|
Market Closed -
Other stock markets
|
After hours 01:00:00 | |||
| 71.25 USD | +3.47% |
|
70.39 | -1.21% |
| 05:50pm | Alert from law firm on Dexcom withdrawn | RE |
| 06-23 | Deutsche Bank Initiates Coverage on DexCom With Buy Rating, $86 Price Target | MT |
Company Valuation: DexCom, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 52,042 | 43,740 | 47,945 | 30,377 | 25,885 | 27,493 | - | - |
| Change | - | -15.95% | 9.61% | -36.64% | -14.79% | 6.21% | - | - |
| Enterprise Value (EV) 1 | 52,692 | 45,068 | 49,813 | 31,073 | 26,209 | 27,088 | 26,282 | 25,272 |
| Change | - | -14.47% | 10.53% | -37.62% | -15.65% | 3.36% | -2.98% | -3.84% |
| P/E | 346x | 138x | 95.5x | 54.8x | 31.8x | 29.1x | 24.4x | 20.3x |
| PBR | 23.1x | 20.5x | 23.1x | 15.1x | 9.3x | 10.1x | 8.64x | 6.58x |
| PEG | - | 1x | 1.6x | 5.94x | 0.7x | 1.7x | 1.3x | 1x |
| Capitalization / Revenue | 21.3x | 15x | 13.2x | 7.53x | 5.55x | 5.26x | 4.72x | 4.21x |
| EV / Revenue | 21.5x | 15.5x | 13.8x | 7.7x | 5.62x | 5.18x | 4.51x | 3.87x |
| EV / EBITDA | 111x | 60x | 49.1x | 28.1x | 19.4x | 16.5x | 13.7x | 11.3x |
| EV / EBIT | 142x | 92.9x | 69.3x | 41x | 27x | 22.3x | 18.3x | 14.7x |
| EV / FCF | 989x | 148x | 97.3x | 49.3x | 24.3x | 27.3x | 21.1x | 16.7x |
| FCF Yield | 0.1% | 0.68% | 1.03% | 2.03% | 4.11% | 3.67% | 4.73% | 6% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 0.3875 | 0.82 | 1.3 | 1.42 | 2.09 | 2.448 | 2.921 | 3.51 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 2,448 | 2,910 | 3,622 | 4,033 | 4,662 | 5,225 | 5,830 | 6,523 |
| EBITDA 1 | 472.7 | 751.6 | 1,014 | 1,105 | 1,349 | 1,639 | 1,915 | 2,228 |
| EBIT 1 | 370.7 | 485.1 | 718.6 | 757.1 | 969.3 | 1,212 | 1,438 | 1,723 |
| Net income 1 | 154.7 | 341.2 | 541.5 | 576.2 | 836.3 | 962.6 | 1,158 | 1,378 |
| Net Debt 1 | 650.1 | 1,328 | 1,868 | 695.9 | 323.2 | -405 | -1,211 | -2,221 |
| Reference price 2 | 134.24 | 113.24 | 124.09 | 77.77 | 66.37 | 71.25 | 71.25 | 71.25 |
| Nbr of stocks (in thousands) | 387,688 | 386,258 | 386,374 | 390,595 | 390,016 | 385,873 | - | - |
| Announcement Date | 10/02/22 | 09/02/23 | 08/02/24 | 13/02/25 | 12/02/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 29.11x | 5.18x | 16.53x | -.--% | 27.49B | |
| 23.6x | 3.54x | 13.29x | 2.67% | 166B | |
| 18.86x | 3.29x | 11.59x | 3.56% | 106B | |
| 16.3x | 0.18x | 11.67x | 0.8% | 57.69B | |
| 32.35x | 7.85x | 20.53x | 1.24% | 53.2B | |
| 39.39x | 3.1x | 10.64x | 2.44% | 43.56B | |
| 41.35x | 1.48x | 13.02x | 0.19% | 36.52B | |
| 43.44x | 7.53x | 27.19x | 0.24% | 25.84B | |
| 24x | 3.51x | 12.61x | 1.21% | 21.27B | |
| 46.52x | 6.23x | 20.02x | 0.47% | 20.28B | |
| Average | 31.49x | 4.19x | 15.71x | 1.28% | 55.85B | |
| Weighted average by Cap. | 27.20x | 3.75x | 14.28x | 1.95% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- DXCM Stock
- Valuation DexCom, Inc.
Select your edition
All financial news and data tailored to specific country editions
